ZP
ZPTAW
Zapata Quantum, Inc.
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$122.00
SEC Reports6
Recent Activity
Jun 5, 2026
SEC
Zapata Quantum files an S-1 registration statement to register 56,816,391 shares of common stock for resale by selling s
S-1 — Impact 6/10
May 7, 2026
SEC
Clark Golestani filed an amended Form 3 to correct the reporting basis from Section 12(b) to Section 12(g) after Zapata
3/A — Impact 2/10
Apr 24, 2026
SEC
Zapata Quantum completed a $15 million unregistered private placement led by Triatomic Capital, with proceeds intended t
8-K — Impact 7/10
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $120.00 | — |
| MORGAN STANLEY | $2.00 | — |
2 institutional holders with $122.00 total value (3,395 shares) as of 2024-Q3. Top holders: UBS, MORGAN.
Top Institutional Holders — 2024-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 3,343 | $120.00 | 98.4% | — |
| 2 | MORGAN STANLEY | 52 | $2.00 | 1.6% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 4 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
BEARISH
S-1
6/10
Zapata Quantum files an S-1 registration statement to register 56,816,391 shares of common stock for
Jun 5, 2026
NEUTRAL
3/A
2/10
Clark Golestani filed an amended Form 3 to correct the reporting basis from Section 12(b) to Section
May 7, 2026
BULLISH
8-K
7/10
Zapata Quantum completed a $15 million unregistered private placement led by Triatomic Capital, with
Apr 24, 2026
BEARISH
8-K
7/10
Zapata Quantum raised $4.565 million through an unregistered offering of 4,565 shares of Series D Co
Apr 24, 2026
BEARISH
8-K
6/10
Zapata Quantum, Inc. raised $3.75 million through an unregistered offering of 3,750 shares of Series
Apr 15, 2026
BEARISH
8-K
6/10
Zapata Quantum is raising up to $15 million through an unregistered private placement of Series D Co
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2024-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.